ARVN · Arvinas Inc
United States · RS rating 26 · As of 2026-11-03
| Price | 7.09 USD |
|---|---|
| 1-day change | -5.7% |
| RS rating (overall / 1M / 3M / 12M) | 26 / 45 / 37 / 31 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 15 / 6 / 19 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -129.2% |
| Sales growth Q/Q | -77.3% |
| Distance from 52-week high | +48.7% |
| Market cap (USD) | $666.5M |